1. Home
  2. QVCGA vs CVKD Comparison

QVCGA vs CVKD Comparison

Compare QVCGA & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QVCGA
  • CVKD
  • Stock Information
  • Founded
  • QVCGA 1991
  • CVKD 2022
  • Country
  • QVCGA United States
  • CVKD United States
  • Employees
  • QVCGA N/A
  • CVKD N/A
  • Industry
  • QVCGA
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • QVCGA
  • CVKD Health Care
  • Exchange
  • QVCGA NYSE
  • CVKD Nasdaq
  • Market Cap
  • QVCGA 26.1M
  • CVKD 29.5M
  • IPO Year
  • QVCGA N/A
  • CVKD 2023
  • Fundamental
  • Price
  • QVCGA $2.78
  • CVKD $12.54
  • Analyst Decision
  • QVCGA
  • CVKD Strong Buy
  • Analyst Count
  • QVCGA 0
  • CVKD 1
  • Target Price
  • QVCGA N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • QVCGA 112.9K
  • CVKD 36.2K
  • Earning Date
  • QVCGA 08-07-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • QVCGA N/A
  • CVKD N/A
  • EPS Growth
  • QVCGA N/A
  • CVKD N/A
  • EPS
  • QVCGA N/A
  • CVKD N/A
  • Revenue
  • QVCGA $9,800,000,000.00
  • CVKD N/A
  • Revenue This Year
  • QVCGA $2.89
  • CVKD N/A
  • Revenue Next Year
  • QVCGA $0.45
  • CVKD N/A
  • P/E Ratio
  • QVCGA N/A
  • CVKD N/A
  • Revenue Growth
  • QVCGA N/A
  • CVKD N/A
  • 52 Week Low
  • QVCGA $2.27
  • CVKD $5.70
  • 52 Week High
  • QVCGA $39.74
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • QVCGA N/A
  • CVKD 49.98
  • Support Level
  • QVCGA N/A
  • CVKD $11.00
  • Resistance Level
  • QVCGA N/A
  • CVKD $13.56
  • Average True Range (ATR)
  • QVCGA 0.00
  • CVKD 1.15
  • MACD
  • QVCGA 0.00
  • CVKD 0.25
  • Stochastic Oscillator
  • QVCGA 0.00
  • CVKD 80.97

About QVCGA QVC GROUP INC

QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: